CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 9 Months Ended |
Dec. 31, 2022 | Dec. 31, 2021 |
Cash flows from operating activities: | | |
Net income (loss) | $ 3,393,653 | $ 1,214,011 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (3,596,277) | (2,032,167) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 3,788 | 4,040 |
(Decrease) Increase in accounts payable and accrued expenses | 359,621 | (27) |
(Decrease) Increase in accounts payable affiliates | (1,764,414) | (1,181,978) |
Net cash used in operating activities | (1,603,629) | (1,996,121) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 3,596,277 | 2,032,167 |
Net cash provided by investing activities | 3,596,277 | 2,032,167 |
Cash flows from financing activities: | | |
Distributions | (3,471,447) | (5,940,309) |
Net cash used in financing activities | (3,471,447) | (5,940,309) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (1,478,799) | (5,904,263) |
Cash and cash equivalents, beginning | 2,370,898 | 10,819,585 |
Cash and cash equivalents, ending | 892,099 | 4,915,322 |
Series 20 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 21 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 22 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 23 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 24 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 25 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 26 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | (91,580) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (20,845) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 75 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | (2,199) |
Net cash used in operating activities | 0 | (114,549) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 20,845 |
Net cash provided by investing activities | 0 | 20,845 |
Cash flows from financing activities: | | |
Distributions | 0 | (437,323) |
Net cash used in financing activities | 0 | (437,323) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (531,027) |
Cash and cash equivalents, beginning | 0 | 531,027 |
Cash and cash equivalents, ending | 0 | 0 |
Series 27 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 28 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 29 | | |
Cash flows from operating activities: | | |
Net income (loss) | (56,727) | (25,940) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (29,999) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | (352) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 3,384 | (19,965) |
Net cash used in operating activities | (53,343) | (76,256) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 29,999 |
Net cash provided by investing activities | 0 | 29,999 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (53,343) | (46,257) |
Cash and cash equivalents, beginning | 108,768 | 164,236 |
Cash and cash equivalents, ending | 55,425 | 117,979 |
Series 30 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 31 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 32 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | (81,264) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (23,823) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 74 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | (4,847) |
Net cash used in operating activities | 0 | (109,860) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 23,823 |
Net cash provided by investing activities | 0 | 23,823 |
Cash flows from financing activities: | | |
Distributions | 0 | (2,554,377) |
Net cash used in financing activities | 0 | (2,554,377) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (2,640,414) |
Cash and cash equivalents, beginning | 0 | 2,640,414 |
Cash and cash equivalents, ending | 0 | 0 |
Series 33 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | (87,109) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (23,823) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 74 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | (4,992) |
Net cash used in operating activities | 0 | (115,850) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 23,823 |
Net cash provided by investing activities | 0 | 23,823 |
Cash flows from financing activities: | | |
Distributions | 0 | (2,948,609) |
Net cash used in financing activities | 0 | (2,948,609) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (3,040,636) |
Cash and cash equivalents, beginning | 0 | 3,040,636 |
Cash and cash equivalents, ending | 0 | 0 |
Series 34 | | |
Cash flows from operating activities: | | |
Net income (loss) | (54,579) | (51,349) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 74 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 13,869 | 13,869 |
Net cash used in operating activities | (40,710) | (37,406) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (40,710) | (37,406) |
Cash and cash equivalents, beginning | 81,705 | 129,067 |
Cash and cash equivalents, ending | 40,995 | 91,661 |
Series 35 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 36 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 37 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 38 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 39 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 40 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 41 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | (101,698) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 437 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | (1) |
(Decrease) Increase in accounts payable affiliates | 0 | 26,682 |
Net cash used in operating activities | 0 | (74,580) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (74,580) |
Cash and cash equivalents, beginning | 0 | 408,743 |
Cash and cash equivalents, ending | 0 | 334,163 |
Series 42 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 46,529 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (94,182) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | (419) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 12,150 |
Net cash used in operating activities | 0 | (35,922) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 94,182 |
Net cash provided by investing activities | 0 | 94,182 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 58,260 |
Cash and cash equivalents, beginning | 0 | 2,318,856 |
Cash and cash equivalents, ending | 0 | 2,377,116 |
Series 43 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash used in operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Series 44 | | |
Cash flows from operating activities: | | |
Net income (loss) | 1,755,220 | 774,916 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (1,746,178) | (815,747) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 205 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | (26) |
(Decrease) Increase in accounts payable affiliates | (28,269) | (379,155) |
Net cash used in operating activities | (19,227) | (419,807) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 1,746,178 | 815,747 |
Net cash provided by investing activities | 1,746,178 | 815,747 |
Cash flows from financing activities: | | |
Distributions | (2,957,455) | 0 |
Net cash used in financing activities | (2,957,455) | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (1,230,504) | 395,940 |
Cash and cash equivalents, beginning | 1,230,504 | 842,738 |
Cash and cash equivalents, ending | 0 | 1,238,678 |
Series 45 | | |
Cash flows from operating activities: | | |
Net income (loss) | 1,364,970 | 618,081 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (1,411,858) | (691,381) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 2,627 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | (1,138,508) | (618,340) |
Net cash used in operating activities | (1,185,396) | (689,013) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 1,411,858 | 691,381 |
Net cash provided by investing activities | 1,411,858 | 691,381 |
Cash flows from financing activities: | | |
Distributions | (513,992) | 0 |
Net cash used in financing activities | (513,992) | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (287,530) | 2,368 |
Cash and cash equivalents, beginning | 287,530 | 294,663 |
Cash and cash equivalents, ending | 0 | 297,031 |
Series 46 | | |
Cash flows from operating activities: | | |
Net income (loss) | 384,769 | 213,425 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (438,241) | (332,367) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 3,788 | 1,245 |
(Decrease) Increase in accounts payable and accrued expenses | 359,621 | 0 |
(Decrease) Increase in accounts payable affiliates | (614,890) | (205,181) |
Net cash used in operating activities | (304,953) | (322,878) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 438,241 | 332,367 |
Net cash provided by investing activities | 438,241 | 332,367 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 133,288 | 9,489 |
Cash and cash equivalents, beginning | 662,391 | 449,205 |
Cash and cash equivalents, ending | $ 795,679 | $ 458,694 |